The doctrine, the full derivation, and the interactive tool are all open. If you intend to rely on its outputs, please read the scope and limitations first — and get in touch for support or a briefing.
dcsvelan@gmail.com
Please include RISK TRANSLATOR in the subject line.
This project is a method demonstration from VELANS. The primary work is elsewhere.
VELANS builds pharmacokinetic and pharmacodynamic software for individualising dosage regimens of narrow-therapeutic-index drugs — a development line begun in 1990.
The same discipline demonstrated here is the discipline applied there: derive rather than assume, report the interval rather than the point estimate, state the limitations alongside the result, and record a falsification when the data refutes an assumption.